Clonidine Transdermal System
In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised the Clonidine Transdermal System monograph. The purpose for the revision is to add Drug Release Test 3 for a new generic product.
The Clonidine Transdermal System Revision Bulletin supersedes the currently official Clonidine Transdermal System monograph. The Revision Bulletin will be incorporated in USP 35–NF 30.
Should you have any questions, please contact Sujatha Ramakrishna Ph.D, M.B.A. (301-816-8349 or sxr@usp.org).


Follow Us On: